Repository Corticotropin in Treating De-Novo C3 Glomerulonephritis Post-Transplantation
Introduction: De-novo C3 glomerulonephritis (C3GN) post-transplant is uncommon. Although eculizumab has been used successfully in several cases, the response is heterogeneous and treatment strategies remain undefined. The use of repository corticotropin in C3GN has not been described in the literatu...
Enregistré dans:
Auteurs principaux: | Muhammad Saad Naseer, Ayush Singh, Neeraj Singh |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Karger Publishers
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/290bca6c394f4e81afb2c8d4c95e74a4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Immunoglobulin-negative fibrillary glomerulonephritis masked in diabetic nephropathy: A case report and discussion of a diagnostic pitfall.
par: Gabriel B.W. Lerner, et autres
Publié: (2021) -
Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa
par: Hajime Kato, et autres
Publié: (2021) -
Maternal and Fetal Outcomes in Women with Diabetes in Pregnancy Treated before and after the Introduction of a Standardized Multidisciplinary Management Protocol
par: Maddalena Morlando, et autres
Publié: (2021) -
Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
par: Reham Z. Hamza, et autres
Publié: (2021) -
Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin
par: C Wright, et autres
Publié: (2021)